UncategorizedGenetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance 1 week ago01 mins GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. read more Post navigation Previous: Intel Strengthens Ties with China, Invests $300 Million to Expand Chip OperationsNext: Roku Q3 Earnings Preview: Can Platform Revenue Growth Exceed Expectations? Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Lucid Rises Nearly 5% In Pre-Market After Strong Q3 Results, Opening Orders For Gravity SUV 1 hour ago 0
Market Surge Predicted To Reach 10% By Year-End As Trump Victory Fuels Stock Rally, Says Fundstrat’s Tom Lee 1 hour ago 0
‘We Need To Do A Better Job Of Procuring The Defense Tools:’ Anduril Founder Palmer Luckey Explains Why Donald Trump’s Strategy Could Be The Future 1 hour ago 0